glp 1 agonists for alcohol use disorder IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance disorders: An emerging pharmacotherapeutic target GLP-1 Receptor Agonists as Treatments
Description
Garvey, W
A few studies suggested that stopping GLP-1s is associated with regaining at least a portion of the lost weight, but its possible that if you go slowly, you may be more likely to keep the weight off
Mattson MP, Magnus T
Liraglutide inhibits the proliferation and promotes the apoptosis of MCF-7 human breast cancer cells through downregulation of microRNA-27a expression
Association of semaglutide with risk of suicidal ideation in a real-world cohort
The safety profile of GLP-1 injections is well-established, with many individuals experiencing minimal side effects
